Thema: US24823R1059
DNLI, US24823R1059
trading-7181177_1280.jpg - Foto: THN
Denali Therapeutics stock draws focus after AVLAYAH award
Denali Therapeutics stock enters a key week after AVLAYAH won the 2026 Prix Galien USA biotechnology award. Results follow on November 3.
ad-hoc-news.de, heute 19:12 Uhr
DNLI, US24823R1059
Wedbush cuts target for Denali Therapeutics stock from USD ...
Results are due November 3, 2026. Denali Therapeutics stock costs EUR 17.28 on October 27, 2026, plus 5.85 percent versus the Frankfurt close.
ad-hoc-news.de, 27.10.26 21:04 Uhr
DNLI, US24823R1059
Wedbush cuts Denali target to USD 23 for Denali Therapeutics ...
Denali reports third-quarter results on November 3, 2026. Denali Therapeutics stock costs EUR 16.43 on October 24, 2026 during trading.
ad-hoc-news.de, 24.10.26 20:17 Uhr
DNLI, US24823R1059
DNLI stock: November 5 results date guides Denali Therapeutics ...
Q3 2026 revenue is forecast at USD 12.22 million. Denali Therapeutics stock costs EUR 16.56 on October 22, 2026 at 6:35 p.m. CEST after hours.
ad-hoc-news.de, 22.10.26 18:41 Uhr
DNLI, US24823R1059
Wedbush cuts target to USD 23: Denali Therapeutics stock ...
Denali reports results on November 5, 2026. Denali Therapeutics stock costs EUR 17.01 on October 20, 2026, up 5.13 percent versus Frankfurt close.
ad-hoc-news.de, 20.10.26 21:04 Uhr
DNLI, US24823R1059
Denali Therapeutics stock sits 28.07 percent above its 52-week ...
Results are estimated for November 5, 2026. Denali Therapeutics stock closed at USD 17.61 on October 16, 2026, down 3.98 percent versus prior close.
ad-hoc-news.de, 17.10.26 20:14 Uhr
DNLI, US24823R1059
Wall Street Zen cuts Denali Therapeutics stock to sell as ...
Revenue is USD 12.22 million for the third quarter. Denali Therapeutics stock costs EUR 16.39 on October 15, 2026, up 2.12 percent versus the Frankfurt close.
ad-hoc-news.de, 15.10.26 22:05 Uhr
DNLI, US24823R1059
Denali Therapeutics stock stood 29.1 percent below its yearly ...
Denali Therapeutics stock posted USD 3.60 million in second-quarter revenue on August 6 2026 above the USD 2.15 million estimate. Diluted EPS was a USD 0.68 loss while third-quarter ...
ad-hoc-news.de, 08.10.26 03:54 Uhr
DNLI, US24823R1059
Denali Therapeutics stock falls 3.16 percent as launch metrics ...
Denali Therapeutics stock was down 3.16 percent on October 6, 2026, with the latest quote at USD 19.28. Q2 revenue reached USD 3.60 million.
ad-hoc-news.de, 07.10.26 03:20 Uhr
